Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients

被引：12
|
作者：
Gruson, Damien [1 ,2 ,3 ]
Ferracin, Benjamin [2 ,3 ]
Ahn, Sylvie A. [4 ,5 ]
Rousseau, Michel F. [4 ,5 ]
机构：
[1] Clin Univ St Luc, Inst Rech Expt & Clin, Pole Rech Endocrinol Diabet & Nutr, B-1200 Brussels, Belgium
[2] Clin Univ St Luc, Dept Lab Med, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, Inst Rech Expt & Clin, Clin Univ St Luc, Div Cardiol, B-1200 Brussels, Belgium
[5] Catholic Univ Louvain, Inst Rech Expt & Clin, Div Cardiol, Pole Rech Cardiovasc, B-1200 Brussels, Belgium
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 189卷
关键词：
FGF-23; Galectin-3; ST2; NT-proBNP; BNP; Biomarker; Heart failure; Prognosis; EXPRESSION; PREDICTOR;
D O I：
10.1016/j.ijcard.2015.04.074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：185 / 187
页数：3
相关论文
共 50 条
  • [31] Gal-3 and ST2 Biomarkers - A Step Forward in Heart Failure Prognostication
    Barbosa, Mario
    Matos, Andreia
    Bicho, Manuel
    Falcao, Luiz Menezes
    GALICIA CLINICA, 2021, 82 (03): : 146 - 151
  • [32] The Value of Galectin-3 and ST-2 for Prediction of Prognosis in Patients with Acute Decompensated Heart Failure
    Sugano, Akinori
    Seo, Yoshihiro
    Ishizu, Tomoko
    Yamamoto, Masayoshi
    Hamada, Yoshie
    Machino-Ohtsuka, Tomoko
    Obara, Kenichi
    Ichikawa, Kimito
    Aonuma, Kazutaka
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S181 - S182
  • [33] Galectin-3 and ST-2: association with inflammation and renal dysfunction in patients with chronic heart failure
    Medvedeva, E. A. Elena
    Shiljaeva, N. V.
    Shchukin, Y. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 393 - 393
  • [34] Soluble ST2, Galectin-3 and clinical prognosis of patients with hypertrophic cardiomyopathy undergoing ventricular septal myectomy: a correlation analysis
    Song, Bangrong
    Yao, Bo
    Dang, Haiming
    Dong, Ran
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2020, 10 (02) : 145 - 152
  • [35] Relationship between soluble ST2,galectin-3 and clinical prognosis of ventricular septal myectomy in patients with obstructive hypertrophic cardiomyopathy
    鲁洁
    China Medical Abstracts (Internal Medicine), 2018, 35 (02) : 90 - 90
  • [36] Galectin-3 and ST-2: association with oxidative stress and renal dysfunction in patients with heart failure
    Medvedeva, E. A.
    Shchukin, Y. V.
    Shilyaeva, N. V.
    EUROPEAN HEART JOURNAL, 2016, 37 : 912 - 913
  • [37] Low Galectin-3 Identifies Heart Failure Patients at Minimal Risk for Death or Rehospitalization
    Meijers, Wouter C.
    de Boer, Rudolf A.
    van Veldhuisen, Dirk J.
    Jaarsma, Tiny
    Maisel, Alan S.
    Somma, Salvatore D.
    Peacock, W. F.
    CIRCULATION, 2014, 130
  • [38] Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure
    Wang, Chao-Hung
    Yang, Ning-I
    Liu, Min-Hui
    Hsu, Kuang-Hung
    Kuo, Li-Tang
    CARDIOLOGY JOURNAL, 2016, 23 (05) : 563 - 572
  • [39] Prognostic implication of biomarkers ST2, NT-proBNP, Galectin-3 during long-term observation in patients with advanced heart failure
    Kurlianskaya, A. K. Alena
    Kaliadka, M. G.
    Denisevich, T. L.
    Ostrovsky, Y. P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 349 - 349
  • [40] Soluble ST2 in Patients with Nonvalvular Atrial Fibrillation and Prediction of Heart Failure
    Chen, Changxi
    Qu, Xiang
    Gao, Zhan
    Zheng, Gaoshu
    Wang, Yi
    Chen, Xiao
    Li, Haiying
    Huang, Weijiang
    Zhou, Hao
    INTERNATIONAL HEART JOURNAL, 2018, 59 (01) : 58 - 63
12345